Determining the appropriate retatrutide amount is absolutely necessary for seeing desired outcomes . Initially, patients typically start with a introductory dose of approximately 2.4 mg, administered once week via subcutaneous . This starting amount is then progressively boosted every four periods, reaching a maximum dose of 10.8 mg, according to